首页|门诊处方综合点评及干预措施

门诊处方综合点评及干预措施

Comprehensive review of hospital outpatient prescriptions and intervention measures

扫码查看
目的 综合点评医院样本患者的门诊处方,并提出干预措施.方法 随机抽取2022年10~12月门诊点评处方共5 460张,按照规定逐张进行点评;总结不合理处方数比例以及存在的关键问题.结果 本研究所抽取的5460张门诊处方点评中,存在不合理用药情况的有368张,不合理率6.7%,主要为书写不规范(12.8%)、超常处方(14.7%)、超说明书用药(19.0%)、辅助用药(17.1%)和用法用量不当(10.6%).结论 本院严格贯彻药师处方审核主导原则,不断加强处方审核流程,实施处方前置实时审核,促进合理用药,保障患者用药安全,提高临床医疗质量.
Objective To comprehensively review the outpatient prescriptions of sample patients in our hospital,thus proposing intervention measures.Methods A total of 5460 outpatient review prescriptions from October to December 2022 were randomly collected and reviewed one by one according to the regulations.The proportion of irrational prescriptions and the key problems were summarized.Results Among reviews for 5460 outpatient prescription collected in this study,there were 368(6.7%)irrational drug use,which mainly included non-standard writing(12.8%),abnormal prescription(14.7%),off-label drug use(19.0%),adjuvant drug use(17.1%)and improper usage and dosage(10.6%).Conclusion Our hospital will strictly implement the principle of pharmacist prescription review,continuously strengthen the prescription review process,implement pre prescription real-time review,promote rational medication,ensure patient medication safety,and improve clinical medical quality.

commentoutpatient prescriptionpre-auditrational drug use

陈燕、吉秋霞

展开 >

226600 江苏省海安市人民医院药剂科

点评 门诊处方 前置审核 合理用药

南通市卫生健康委员会科研立项课题

QB2021028

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(15)